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Background: Oxygen is designated an essential drug by the World 
Health Organisation, and reduces mortality in hypoxic patients. In 
low-resource settings the provision of oxygen seldom meets its 
demand. This study explores predictors and observed time-course of 
hypoxaemia in order to help inform needs assessments for oxygen in 
hospitals in low- and middle-income countries. 
Methods: A prospective cohort study of adults with hypoxaemia 
admitted to medical wards of a teaching hospital in Malawi between 
February and March 2020. Vital signs and oxygen therapy were 
recorded daily. We analysed outcomes (death, discharge from hospital 
or ongoing inpatient care at 14 days after admission) using Kaplan-
Meier and Cox regression time-to-event analysis. 
Results: 33 patients were recruited with median age 45 years (IQR 33-
61). 13 (39%) were female. Median pre-treatment oxygen saturations 
were 84% (IQR 76-87%). Oxygen delivery devices were often shared 
with other patients (n=10, 33%) and the flow rate was often unknown 
(n=14, 47%), mostly because of broken equipment (n=8, 57%). Median 
duration of oxygen therapy was 3 days (IQR 1-7). Death occurred in 16 
(49%). Hazard ratios for short oxygen therapy were reduced in 
patients who had a chest radiograph performed (HR 0.08, 95% CI 
0.02–0.30), in ex-smokers (HR 0.01, 95% CI 0.00-0.22) and in never 
smokers (HR 0.03, 95% CI 0.00 – 0.78). 
Conclusions: Delivering oxygen therapy in lower-middle income 
countries is challenging; broken equipment and shared delivery 
devices prevented titration of flow rates. Patients were relatively 
young and at a high risk of death. Patients with a chest radiograph 
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received oxygen for longer than those without. This hypothesis 
generating study can be used to build a more comprehensive 
understanding of oxygen supply need at the hospital level.
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          Amendments from Version 1
We would like to thank the peer reviewers for the comments on 
our manuscript and hope that the changes made reflect some of 
their feedback.
In particular we have now highlighted clearly the limitations 
to our study, most importantly the fact it is single centred and 
has a short period. Whilst we recognize that our results may 
not be fully generalizable, the results can be used to generate 
hypothesis and thus have suggested possible relevant future 
studies.
We have also clarified how 33 participants were included in the 
study, and that 3 patients or their families declined consent 
to participation. We have explained how we believe that we 
have accurately identified all hypoxaemic patients during the 
study period due to the AETC triage system as well as the daily 
recordings of oxygen saturations.
Finally, we have corrected our study dates in the abstract and 






Oxygen reduces morbidity and mortality in hypoxaemic patients, 
and is listed as an essential drug by the World Health Organi-
sation (WHO) (Sittichanbuncha et al. (2015); World Health 
Organization, 2015c). If untreated, failure of oxygen supply to 
tissues precipitates organ failure and death (Sittichanbuncha 
et al. (2015)). Supplemental oxygen can prevent hypoxia, and 
in paediatric studies has reduced pneumonia mortality by 35% 
(Duke et al., 2008). However, supply in resource-limited set-
tings is frequently restricted by availability, equipment cost 
and maintenance difficulties (Enarson et al., 2008; Evans et al., 
2012; La Vincente et al., 2011). Prominent causes of hypoxae-
mia are lower respiratory tract infections, which cause 3 million 
annual deaths globally and 15,000 deaths in Malawi alone, 
which represent 9% of the national mortality, and are the 
most common cause of adult hospitalization (GBD 2015 LRI 
Collaborators, 2017; SanJoaquin et al., 2013).
Previous studies in a regional hospital in Malawi (Queen 
Elizabeth Central Hospital, Blantyre; QECH) showed that 
less than one-third of patients that required supplemental oxy-
gen received it, highlighting the disparity between supply and 
demand (Evans et al., 2012). This prospective cohort study 
explored the observed time course of hypoxaemia and predic-
tors of supplemental oxygen therapy requirements in medical 
patients in Blantyre to help inform needs assessment for oxygen 
at the hospital level.
Methods
Setting and study design
We conducted a prospective cohort study of adults with 
hypoxaemia at the QECH in Blantyre, Malawi, between 
18th February 2020 and 20th March 2020. The hospital has 
200 medical beds, providing healthcare to approximately 
1 million people in a context of high community prevalence of 
human immunodeficiency virus (HIV, 10.6%) and incidence of 
tuberculosis (159 cases per 100,000 population) (‘Government 
of Malawi’, 2015; World Health Organization, 2015a; World 
Health Organization, 2017).
Adults, aged 18 years and above, were included if they were 
hypoxaemic, were treated with supplemental oxygen and were 
admitted under the medical teams. Hypoxaemia was defined 
as peripheral oxygen saturations of less than 90% by finger 
pulse oximetry. Hypoxaemic patients were identified at triage 
in the emergency department, or from daily pulse oxime-
try assessment within 48 hours of admission to the medi-
cal wards. Written, informed consent was gained before any 
data collection was commenced. Those unwilling to consent to 
participation and those not  receiving supplemental oxygen were 
excluded.
Data collection
Baseline demographics, admission details including vital signs 
and oxygen delivery method, diagnoses and co-morbidities were 
documented on admission. Diagnoses made by the attending 
physician and the haemoglobin level  were extracted from medi-
cal notes. Results of chest radiograph performed at any point 
during the admission were recorded. Vital signs and details 
of supplemental oxygen delivery were recorded daily for partici-
pants until outcomes were determined (i.e. death, discharge, or 
ongoing inpatient care after 14 days). Oxygen saturations were 
measured with oxygen therapy present and then with tempo-
rary removal of supplemental oxygen, providing it was clini-
cally safe to do so. Data were collected using an Open Data 
Kit platform on tablet devices (www.kobotoolbox.org).
Statistical analysis
A sample size of 62 participants was calculated to power the 
study to estimate the duration of oxygen therapy with a 
precision 6 hours with a 95% confidence level, and a standard 
deviation of 24 hours. The primary outcome was the dura-
tion of oxygen therapy in days. Secondary outcomes were the 
availability and delivery of supplemental oxygen, length of 
hospital stay, factors associated with the duration of supplemental 
oxygen provision and clinical outcome.
Data were presented as means, standard deviations, medians, 
ranges or percentages, based on the type and distribution of 
data. Those experiencing other events (death, discharge) before 
the end of the study contributed to the proportional hazard 
until that event. The Kaplan-Meier method was used to assess 
time to event data and probabilities. Time to event in univari-
able analysis was estimated by log-rank test. Cox regression 
models were used for uni- and multi-variable analysis and to 
calculate hazard ratios. Competing risk of events were calcu-
lated using estimated cumulative incidence (Putter et al., 2007). 
Conditional survival analysis was used to predict chances of 
requiring oxygen therapy on given days (Zabor et al., 2013). 
Statistical significance was defined as p<0.05, and 95% confi-
dence intervals given where appropriate. Data were analysed 
using R (R Core Team, 2020).
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Ethical considerations
Ethical approval was gained from the College of Medicine 
Research Ethics Committee, Blantyre, Malawi, (reference number 
P.05/19/2693) and the Liverpool School of Tropical Medi-
cine Research Ethics Committee, United Kingdom (reference 
number 19–088). All participants provided written informed 
consent prior to participating in the study.
Results
Baseline results
Between 18th February 2020 and 11th March 2020 525 patients 
were admitted under the medical team at QECH. 36 patients 
were identified by triage in the emergency department and 
on the medical wards as meeting inclusion criteria, and 33 par-
ticipants were recruited into the study (3 patients or their fami-
lies declined participation). Study recruitment was stopped 
on 11th March due to safety concerns resulting from the 
evolving Coronavirus-19 pandemic, but all already enrolled 
participants were followed up until one of the outcomes 
was achieved. Last day of study follow up was 20th March 
2021. 
Thirteen study participants were women (39.4%). The median 
age was 45 years (interquartile range (IQR) 33–61 years, 
Table 1). One third of participants were HIV positive, two were 
currently receiving treatment for tuberculosis (TB) and six 
Table 1. Demographics and admission parameters of the 33 
included participants. Abbreviations as per main text. Results 
are number (%) unless otherwise indicated.
Variable Number 
(percentage)
Female sex, n (%) 13 (39.4 %)
Age, median (range) 45 (22 – 91)
Co-morbidities
  HIV, n (%) 11 (33 %)
  Receiving anti-retroviral therapy 9 (81%)
  Previous TB treatment, n (%) 6 (18 %)
  Current TB treatment, n (%) 2 (6 %)
  Hypertension, n (%) 7 (21 %)
  Malignancy, n (%) 4 (12 %)
Smoking status
  Current, n (%) 2 (6 %)
  Ex, n (%) 9 (27 %)
  Never, n (%) 22 (67 %)
Presenting symptoms
  Dyspnoea, n (%) 18 (55 %)
  Cough, n (%) 18 (55 %)
Variable Number 
(percentage)
  Fever, n (%) 15 (45 %)
  Productive cough, n (%) 12 (36 %)
  Orthopnoea, n (%) 11 (33 %)
  Headache, n (%) 10 (30 %)
  Chest pain, n (%) 10 (30 %)
Vital signs on admission
Heart rate, beats / min, median (IQR) 109 (89 – 123)
Respiratory rate, breaths / min, median (IQR) 28 (23 – 32)
Temperature, °C, median (IQR) 36.7 (36.1 
– 37.8)
SpO2 on air, %, median (IQR) 84 (76 – 87)
SpO2 with oxygen, %, median (IQR) 98 (95 – 99)
Method of supplemental oxygen on 
admission
Oxygen concentrator, n (%) 11 (33.4 %)
Oxygen cylinder, n (%) 22 (66.6 %)
Sharing device on admission, n (%) 10 (30.3 %)
Interface of oxygen delivery on admission
  Reservoir mask, n (%) 4 (12 %)
  Simple mask, n (%) 6 (18 %)
  Nasal cannula, n (%) 23 (70 %)
Oxygen flow on admission, L/min, median 
(range)
6 (4-6)
Oxygen flow on admission unknown, n (%) 14 (42 %)
Chest radiograph performed, n (%) 14 (42 %)
Haemoglobin test performed, n (%) 20 (61 %)
Haemoglobin level, mg/dL, mean ± SD 11.8 ± 2.6
Length of stay, days, median (IQR) 6 (2 – 9.5)
Length of oxygen therapy, days, median 
(IQR)
3 (1 – 7)
Final diagnosis (can have multiple)
  Pneumonia, n (%) 14 (42 %)
  TB, n (%) 5 (15 %)
  Heart failure, n (%) 5 (15 %)
  Meningitis, n (%) 4 (12 %)
  Sepsis, n (%) 3 (9 %)
Outcome at end of study
  Death, n (%) 16 (48 %)
  Discharge before 14 days, n (%) 9 (27 %)
  Inpatient, n (%) 5 (15 %)
  Lost to follow up, n (%) 3 (9 %)
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had previously been treated for it. The most common present-
ing symptoms were dyspnoea and cough (n=18, 55% each). The 
commonest admission diagnosis was pneumonia (n=14, 42%). 
14 participants had a chest radiograph (CXR) performed dur-
ing their admission (42%), and haemoglobin level was measured 
in 20 participants, mean 11.8g/dL (SD 2.6).
At initiation of oxygen therapy, median oxygen saturation was 
84% (IQR 76–87%), and median respiratory rate 28 breaths 
per minute (IQR 23–32). Most patients received oxygen therapy 
via nasal cannulae (n=23, 77%) supplied by a cylinder (n=22, 
73%). One oxygen source was shared with at least one other 
patient in 10 participants (33%). Median oxygen saturations after 
initiation of oxygen therapy were 98% (IQR 95–99%). Hypox-
aemia resolved in 30 participants (91%). Oxygen flow rate 
at time of initiation of therapy was often unknown due to 
broken equipment (n=14, 42%).
The median period of oxygen therapy was 3 days (IQR 1–7). 
The most frequent outcome was death (n=16, 48%), followed 
by discharged from hospital (n=9, 27%) and continued inpa-
tient at 14 days (n=5, 15%). 75% of deaths occurred by day 
3 of follow up (75%, Figure 1). Three participants were lost 
to follow-up (9%).
Of a total of 167 cumulative follow up days, oxygen was given 
for 107 days (64%, Table 2). During this time, oxygen was 
usually supplied from cylinders (83%) and through nasal 
cannulae (83%). For most days one oxygen source was shared 
between at least two patients (71% of days). The median of 
peripheral saturations whilst receiving supplemental oxygen was 
93% (IQR 88–97%) compared to 91% (IQR 85–96%) without 
supplemental oxygen. The median of oxygen saturations was 
99% when supplemental oxygen was no longer required.
Duration of oxygen therapy
The use of oxygen declined by two-thirds between study 
commencement and day five of follow up, and then approxi-
mately halved from days 5 to 10 and from days 10 to 15 
(Figure 2). Two participants continued to receive supplemen-
tal oxygen up to day 15. The duration of therapy was associated 
with smoking status (p=0.03), the availability of a CXR (p<0.01), 
and the initial delivery device (p<0.01, Figure 3). In the univari-
able Cox regression analysis (Table 3), obtaining a chest radio-
graph had a reduced hazard ratio of still requiring oxygen on 
day 15 (HR 0.04, 95% CI 0.01–0.33, p< 0.01), i.e. an increased 
hazard of prolonged therapy. Requiring a reservoir mask on 
admission had an increased hazard of requiring supplemen-
tal oxygen at the end of the study (HR 14.5, 95% CI 2.28–92.7, 
Figure 1. Competing interest graph of the probability of death (red), discharge (green) or inpatient without supplemental 
oxygen at study end (blue) by length of oxygen therapy (days). Calculated using cumulative incidence functions. Baseline comparison: 
inpatient on day 15 requiring supplemental oxygen therapy.
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Table 2. Description of oxygen delivery whilst on the medical wards by days of 
study. Results are total number (%), unless otherwise specified.
Variable Number (%)
Total days of follow up 167
      Total days that supplemental oxygen was given 107 (64 %)











  Cylinder, n (%) 89 (83 %)
  Concentrator, n (%) 18 (17 %)
Method of facial interface on the ward
  Nasal cannulae, n (%) 89 (83 %)
  Reservoir mask, n (%) 5 (5 %)
  Simple face mask, n (%) 13 (12 %)
Oxygen source and facial interface on the ward
Oxygen cylinder with 
  Nasal cannulae, n (%) 72 (81 %)
  Simple face mask, n (%) 13 (15 %)
  Reservoir mask, n (%) 4 (4 %)
Oxygen concentrator with
  Nasal cannulae, n (%) 17 (94 %)
  Reservoir mask, n (%) 1 (6 %)
Number of people connected to single oxygen source on the 
ward
  Only one person connected 31 (29 %)
  2 persons in total connected to same device 60 (56 %)
  3 persons in total connected to same device 16 (15 %)
Unable to record oxygen flow 91 (85 %)
Reason why oxygen flow could not be reported
  Dial broken 80 (88 %)
  Unknown 11 (12 %)
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p <0.01). CXR, being an ex-smoker, or a never smoker remained 
significantly associated in multivariable analysis (respective 
HR 0.08, 95%CI 0.02–0.30, p<0.01, HR 0.01, 95%CI 
0.00–0.22, p<0.01, and HR 0.03, 95%CI 0.00–0.78, p=0.03). 
There was a statistically non-significant trend to an association 
with age (HR 0.95,95% CI 0.89–1.00, p=0.05). The likelihood of 
receiving supplemental oxygen at the end of the study increased 
with prolonged oxygen therapy (Table 4).
Discussion
Despite oxygen therapy resolving hypoxaemia in most 
participants, mortality was almost 50% and three quarters of 
these deaths occurred in the first three days of admission, indi-
cating that hypoxaemia was a marker of severe underlying 
pathology. It recapitulates previous observations where hypox-
aemia was associated with increased 30-day mortality in adult 
patients with pneumonia (Aston et al., 2019).
In the absence of piped oxygen, it is recommended that oxygen 
concentrators are used when power supply is reliable (such as in 
QECH) as they are comparatively cheap and provide consistent 
oxygen (Duke et al., 2010a; World Health Organization, 
2015b). In our study, which immediately predates the introduc-
tion of an on-site oxygen plant, oxygen cylinders were prefer-
entially used. Oxygen cylinders are used preferentially across 
Africa, as they are cheaper to purchase and easier to use than 
concentrators (Belle et al., 2010; La Vincente et al., 2011). 
Equipment difficulties were evident in our study, notably bro-
ken flow meters, which meant titration was not possible for 91 
of 107 follow up days. Sharing theoxygen source was also 
usual practice, making it difficult to titrate flow rates to the indi-
vidual’s needs, and possibly resulting in wasting of oxygen 
resource or even over-oxygenation. Whilst hyperoxaemia is 
associated with excess mortality (Chu et al., 2018; Kane et al., 
2013), the most common diagnoses in our cohort were pneumo-
nia, TB and heart failure (14(42%), 5(15%) and 5(15%) respec-
tively). Pneumonia, sepsis and heart failure were the commonest 
causes of death (6, 3 and 3 cases respectively). Hence 
hyperoxaemia is unlikely to have affected mortality.
The median duration of supplemental oxygen therapy was 
three days, which was influenced by the large number of early 
Figure 2. Kaplan-Meier curve of overall probability of receiving supplemental oxygen (%) and length of oxygen therapy (days). 
Censored data appear as crosses, grey area: 95 % confidence interval.
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Figure 3. Kaplan-Meier curves of probability of receiving supplemental oxygen and length of oxygen therapy (days) by a) smoking status, 
b) having a chest radiograph and c) initial device used to deliver oxygen. Censored data appears as crosses, grey area: 95% confidence 
interval.
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Table 3. Single and multi-variable hazard ratios (HR) by Cox regression analysis for not 
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0.02 – 0.30
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deaths. Two participants required continuous, supplemental 
oxygen for more than two weeks. These observations could 
be tentatively used in planning oxygen services, and prioritizing 
the use of this finite resource. Previous research from QECH has 
highlighted that hypoxaemic patients often do not receive sup-
plemental oxygen, and similar findings have been recorded 
in other LMICs (Duke et al., 2010b; Evans et al., 2012).
Patients who were investigated with a CXR received oxygen 
for longer than those who had no radiography performed. A 
CXR may have allowed the identification of reversible pathol-
ogy and thus justified the medical decision to continue oxygen 
therapy. However, sicker patients with a higher oxygen require-
ment and poorer prognosis may have been less likely to 
have had a CXR initially, creating confounding bias.
Oxygen therapy duration was also statistically significantly 
associated with the initial delivery interface that was used. 
However, three out of the four participants who were using a 
reservoir mask died, two within two days of admission, indi-
cating sicker patients may have needed a reservoir mask. HIV 
status was not associated with oxygen therapy duration.
Limitations
We recognize that this study was single centered with a rela-
tively small sample size, and thus may only provide a ‘snapshot’ 
of the situation. It is liable to be affected by random error as 
well as selection bias. It was conducted over a short study 
period that only represents one of the seasonal variations that are 
known to affect the number of admissions and severity of ill-
ness, and thus in turn the need for oxygen. It was also not pos-
sible to longitudinally follow flow rates for individual patients 
due to frequent switches between delivery devices as well as 
broken equipment. 
During our recruitment period 535 patients were admit-
ted to medicine, 36 of whom we identified as being hypoxae-
mic (7% admissions). We are confident that we have included 
the majority of patients who were hypoxaemic during the 
study period due to the thorough admission triage process as 
well as close collaboration with staff to identify any newly 
hypoxaemic patients on the wards via daily saturation readings. 
Whilst the results may not be wholly generalizable, they can be 
used to shape further hypothesis. For example, future work 
may explore the association of sharing oxygen devices and 
complications such as nosocomial infections or acute desatu-
rating events. There could also be further exploration into the 
cost of oxygen supply methods which could better inform 
formal health economic analysis. 
Conclusions
It has previously been demonstrated that programmatically 
introducing oxygen in paediatric populations is beneficial 
(Duke et al., 2008), however data from adult practice are few. 
Our study provides some patient-level data which describe 
periods of treatment, and outcomes which could help generate 
further hypothesis to better inform oxygen demand. 
Data availability
Underlying data
DataCat: Supplemental oxygen in Queen Elizabeth Central 
Hospital Malawi: a prospective cohort study of patients admitted 
to medical wards, http://dx.doi.org/10.17638/datacat.liverpool.
ac.uk/1211 (Stolbrink et al., 2021).
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Kathryn Maitland   
Faculty of Medicine, Imperial College London, London, UK 
Thank you for considering my appraisal of the study and including these in the response and 
revisions to the manuscript. 
 
I do note that the authors still have not fully corrected the final statement ' It has previously been 
demonstrated that programmatically introducing oxygen in paediatric populations is beneficial (
Duke et al., 2008)...' with respect to my comments. There are quite a number of limitations of this 
study that does not justify the strength of this statement. May I also point the authors to another 
recent publication, DOI 10.1007/s00134-021-06385-3; that I think would be appropriate to reflect 
on. 
 
With respect to the recent publication I have indicated I am the lead author of that manuscript, 
however I do think its findings, albeit inconclusive, should be reflected upon as well as the 
accompanying editorial (DOI 10.1007/s00134-021-06406-1). 
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Kristina E. Rudd  
Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA 
Thank you for the opportunity to review this manuscript. The authors’ objective was to describe 
the demographics, management, and outcomes of adults admitted to medical wards with 
hypoxemia in a single center in Malawi over a 1-month time period in early 2020. I agree with the 
authors that it is important to study the needs of patients with hypoxemia in low-resource settings 
in order to inform future oxygen resource allocation. A strength of the work includes its 
prospective design. The study is limited by the fact that it is single-center, does not include 
denominator data (specifically, what portion of all patients admitted to the hospital at that time 
did and did not have hypoxemia?), and is very small, with only 33 patients. Unfortunately this very 
small sample size, along with the other limitations of the study, make it impossible to generalize 
the findings in any meaningful way. The paper is interesting, but should be considered hypothesis-
generating work. I think one of the most helpful findings is the authors’ documentation of the 
frequency with which oxygen delivery devices were shared between patients – perhaps further 
examining this practice (which indeed is commonplace in many resource-limited settings though 
not well studied in the medical literature) in a larger future study would be interesting? Relevant 
work could include investigating the association between oxygen device sharing and 
complications such as nosocomial infection or acute desaturation events, and outcomes such as 
hospital mortality or secondary organ dysfunction. 
 
Major Comments:
The authors state that part of their objective was to “explore the observed time course of 
hypoxemia and predictors of supplemental oxygen therapy requirements in medical 
patients…to inform needs assessment of oxygen at the hospital level.” I worry that, given 
the very high mortality rate in this study, difficultly determining individual patients’ oxygen 
flow rates, and severely limited resources, the use / provision of supplemental oxygen in 
this study does not reflect the requirements for oxygen. Therefore any analyses of 
predictors of duration of oxygen therapy at best difficult to interpret and at worst 
completely misleading. For example, in such a resource-limited setting, perhaps it was 
actually the healthier patients with a better chance of survival who received a longer 
duration of oxygen therapy? Or perhaps, given the very small sample size and brief study 
duration, length of oxygen therapy simply reflects provider variation? I would strongly 
suggest removing all of these regression analyses and K-M curves. The authors seem to 
make causal conclusions here that are not substantiated by the results. 
 
1. 
The Results state that 525 patients were admitted under the medical team during the study 2. 
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period. The paper’s quality is significantly diminished by the fact that the authors do not 
include a CONSORT diagram showing the reasons why only 33 people were recruited for 
this study. How many were hypoxic but didn’t receive oxygen? How many were both hypoxic 
and received oxygen, but declined consent?
Minor Comments:
The abstract states that the study took place January – March 2020, but the methods state it 
was 18 Feb – 20 March (actually 18 Feb – 11 March per the results). Please correct whichever 
sections are incorrect. 
 
1. 
Why is no percentage included for the patients receiving ARV therapy (Table 1)?2. 
 
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
No
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Pulmonary and Critical Care clinical research, epidemiology of sepsis and 
critical illness in resource-limited settings.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to state that I do not consider it to be of an acceptable scientific standard, for 
reasons outlined above.
Author Response 25 May 2021
Helen Thomson, Malawi Liverpool Wellcome Trust, Blantyre, Malawi 
Many thanks for the review of the manuscript. Your comments have been reviewed and 
hopefully you can see the reflection of this in our most recent submission. 
 
Of note, we perhaps did not clearly highlight the limitations to our study, and thus have 
added a paragraph about this. We agree this paper is likely hypothesis generating work and 
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have suggested possible relevant future work. 
 
Whilst we have not included a consort diagram, we hopefully have explained in the 
discussion that of the 525 patients admitted under the medical team 36 patients were 
identified as being hypoxaemic and 3 patients/their families declined consent, leading to 33 
participants in the study. We believe that both the triage system in AETC as well as the daily 
recording of oxygen saturations allowed us to highlight all the hypoxaemic patients during 
the study period. 
 
We have corrected the study dates in the abstract and have included the percentage for 
patients receiving ARV therapy.  
Competing Interests: No competing interests were disclosed.
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© 2021 Maitland K. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
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Kathryn Maitland   
Faculty of Medicine, Imperial College London, London, UK 
The introduction starts with a bold statement ‘Oxygen reduces morbidity and mortality in 
hypoxaemic patients and then goes on to state ‘failure of oxygen supply to tissues precipitates 
organ failure and death’. The two references supporting these are a ‘before and after’ 
observational study conducted in Papua New Guinea (Duke et al.) in early 2000’s in children with 
hypoxaemia implying that better use of oxygen (although not actually recorded rate/volume of 
oxygen used) resulted in better outcomes - has numerous potential biases to draw on as definitive 
evidence. The second reference is to a case report (Goldhill) of an elderly gentleman admitted with 
severe pneumonia who received oxygen, escalated to CPAP and the ICU care but died 24 days into 
admission. Perhaps the authors may be more speculative or provide better references to support 
this statement.  
 
The introduction also includes a study conducted in the same hospital (Evans et al. 2016) in 144 
adults including 14 eligible to receive oxygen therapy. Some of the same issues that the current 
paper discusses were brought out. 
 
I noticed that the short period of the study from 18th February 2020 and 20th March 2020 and 
refer the authors (some being co-authors of the Evans paper) to the limitations highlighted in that 
study. ‘as a 24-hour cross-sectional study it only provides a brief snapshot and is open to random error 
as well as information and selection bias. Malawi essentially has three seasons: hot and wet, hot and 
temperate. As a result, there are seasonal variations in the number of admissions as well as the severity 
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of illness with a consequent impact on the need for oxygen’. 
 
My concern is about generalisabilty. I understand that the study halted as a result of COVID – why 
was it not possible restart it once recruitment was allowed? There needs to be some more 
reflection on this limited window of the study.  
 
I note that median O2 sats were 84% on admission and that on oxygen (all received oxygen 
therapy, despite many having to share the supply) median O2 sats were normal 98% (95 – 99). The 
conclusion that sharing oxygen resource needs to be tempered by this fact. 
The authors ‘show’ that having a chest X-ray reduced the risk of dying. This is reported as ‘CXR on 
admission’. Does that mean CXR taken AT admission time (to hospital) or if a CXR was ever taken 
during admission was included in this variable. This is rather problematic both ways. First the 
patients who got a CXR AT admission were probably more likely to less critically sick hence less 
likely to die. If this parameter includes CXR at any time then since most deaths occurred <72 hours 
of admission and likely to be to critical sick to send off for an X-ray it is mostly that these deaths 
did not have a CXR i.e. only only means those who were able to survive long enough to get a chest 
X-ray had a better outcome. Unless the authors have an alternative explanation? 
 
The authors have reported overall use of oxygen used in the study. Is it possible that the authors 
could report median (and interquartile range) of oxygen use per patient in those with known flow 
rates (although assumptions may have to made that this flow rate may not have been constant 
over time)? In addition, it would be very good to provide, based on the cost of a bottle of oxygen, 
how much oxygen therapy cost – other variable costs to include would be mask, tubing etc. There 
is very little published on the ‘costs’ of oxygen therapy. 
 
When discussing the issues of difficulties in providing sustainable sources of oxygen there are 
some reference they may want to include1. These include a survey of oxygen supply and 
associated infrastructure was performed at 231 health centres and hospitals in twelve African 
countries and some more discussion based on this paper for the challenges of using Oxygen 
concentrators, the WHO preferred option, when electricity supplies as reported in this survey at 
most centres was very unreliable. Our research group has also reported on this2. 
 
At the beginning of the discussion the authors note that despite correction of oxygen saturations 
there was a high mortality. It would be good to see some speculation over whether hypoxaemia 
was on the causal pathway to mortality? Oxygen therapy can have risks and benefits - perhaps 
these could be weighed up3, 4? 
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Are all the source data underlying the results available to ensure full reproducibility?
Partly
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Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Critical illness in resource poor hospitals in Africa.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to state that I do not consider it to be of an acceptable scientific standard, for 
reasons outlined above.
Author Response 25 May 2021
Helen Thomson, Malawi Liverpool Wellcome Trust, Blantyre, Malawi 
Many thanks for the review of the manuscript. Your comments have been reviewed and 
hopefully you can see the reflection of this in our most recent submission. 
 
We have now changed our references in our introduction that provide stronger evidence to 
support our statements. We now reference a Thai study including nearly 100,000 patients 
that demonstrate low oxygen saturations to be significantly associated with pre-hospital 
mortality. 
 
We have also added a section exploring the limitations of our study, including the fact it is 
single-centred and has a short period that does not account for seasonal variation in 
Malawi. We recognise that whilst our results may not be fully generalizable, the results can 
be used to generate hypothesis, and we have made suggestions of future relevant work. 
 
In the discussion we have a paragraph related to the presence of a CXR and length of 
oxygen therapy received (‘Patients who were investigated with a CXR received oxygen for longer 
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than those who had no radiography performed. A CXR may…). We agree that there is potential 
for confounding bias in our findings and have hopefully explained this. 
 
Whilst we would have liked to explore the longitudinal relationship of individual patients 
oxygen use, this was not possible due to broken equipment and frequent switching of 
patients oxygen delivery devices. We have referenced the Belle et al. study of oxygen supply 
and associated infrastructure to highlight difficulties in providing sustainable sources of 
oxygen.  
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